A randomized, placebo-controlled clinical trial of docosahexaenoic acid supplementation for X-linked retinitis pigmentosa.

Abstract

PURPOSE Low docosahexaenoic acid (DHA) in X-linked retinitis pigmentosa (XLRP) may influence retinal function. The goals of this study were to elevate blood DHA levels and determine the effect on the rate of disease progression. DESIGN In a 4-year prospective randomized clinical trial, male patients with XLRP (mean age = 16 years; range = 4-38 years… (More)

Topics

Cite this paper

@article{Hoffman2004ARP, title={A randomized, placebo-controlled clinical trial of docosahexaenoic acid supplementation for X-linked retinitis pigmentosa.}, author={Dennis R. Hoffman and Kirsten G. Locke and Dianna Hughbanks Wheaton and Gary Edd Fish and Rand Spencer and David G. W. Birch}, journal={American journal of ophthalmology}, year={2004}, volume={137 4}, pages={704-18} }